A multiomic characterization of the leukemia cell line REH using short- and long-read sequencing.


Journal

Life science alliance
ISSN: 2575-1077
Titre abrégé: Life Sci Alliance
Pays: United States
ID NLM: 101728869

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 14 11 2023
revised: 02 05 2024
accepted: 02 05 2024
medline: 23 5 2024
pubmed: 23 5 2024
entrez: 22 5 2024
Statut: epublish

Résumé

The B-cell acute lymphoblastic leukemia (ALL) cell line REH, with the t(12;21)

Identifiants

pubmed: 38777370
pii: 7/8/e202302481
doi: 10.26508/lsa.202302481
pii:
doi:

Substances chimiques

Oncogene Proteins, Fusion 0
Core Binding Factor Alpha 2 Subunit 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 Lysenkova Wiklander et al.

Auteurs

Mariya Lysenkova Wiklander (M)

https://ror.org/048a87296 Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 SciLifeLab, Uppsala University, Uppsala, Sweden.

Gustav Arvidsson (G)

https://ror.org/048a87296 Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 SciLifeLab, Uppsala University, Uppsala, Sweden.

Ignas Bunikis (I)

https://ror.org/048a87296 SciLifeLab, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 National Genomics Infrastructure, Uppsala University, Uppsala, Sweden.

Anders Lundmark (A)

https://ror.org/048a87296 Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 SciLifeLab, Uppsala University, Uppsala, Sweden.

Amanda Raine (A)

https://ror.org/048a87296 Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 SciLifeLab, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 National Genomics Infrastructure, Uppsala University, Uppsala, Sweden.

Yanara Marincevic-Zuniga (Y)

https://ror.org/048a87296 Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 SciLifeLab, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 National Genomics Infrastructure, Uppsala University, Uppsala, Sweden.

Henrik Gezelius (H)

https://ror.org/048a87296 Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 SciLifeLab, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 National Genomics Infrastructure, Uppsala University, Uppsala, Sweden.

Anna Bremer (A)

https://ror.org/048a87296 SciLifeLab, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
https://ror.org/01apvbh93 Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden.

Lars Feuk (L)

https://ror.org/048a87296 SciLifeLab, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 National Genomics Infrastructure, Uppsala University, Uppsala, Sweden.

Adam Ameur (A)

https://ror.org/048a87296 SciLifeLab, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 National Genomics Infrastructure, Uppsala University, Uppsala, Sweden.

Jessica Nordlund (J)

https://ror.org/048a87296 Department of Medical Sciences, Uppsala University, Uppsala, Sweden jessica.nordlund@medsci.uu.se.
https://ror.org/048a87296 SciLifeLab, Uppsala University, Uppsala, Sweden.
https://ror.org/048a87296 National Genomics Infrastructure, Uppsala University, Uppsala, Sweden.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH